glp 1 agonist and pregnancy Maternal cardiometabolic health the role of GLP-1 receptor agonists from preconception to postpartum: A review of evidence and opportunities GLP-1 weight-loss drugs pose hidden

We then performed two-sample MR and SMR analyses to estimate the association between gene expression of GLP-1 RAs drug target and mood disorders using eQTL data and GWAS summary statistics

What do they want to achieve

However, the best drug is always the one that is right for your individual health profile, medical history, and goals not the one with the highest headline number

[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Yarchoan M, et al

His work focuses on how microbial ecosystems interact with human physiology, including: Gut barrier function and intestinal permeability Mucus-associated microbiota (Akkermansia-related systems) Oralgut microbiome axis Short-chain fatty acids (SCFAs) and metabolic signaling Circadian rhythmmicrobiome interactions Clinical Research Contributions He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including: Active Ulcerative Colitis (Inflammatory Bowel Disease) Hyperoxaluria (Oxalate Metabolism Disorder) Microbiome-driven gut health and inflammatory conditions These studies were part of broader clinical development programs evaluating microbiome-based approaches